Patents by Inventor Huw Davies

Huw Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150315978
    Abstract: A method of controlling a supply of a fuel to a combustor of a gas turbine having a compressor upstream of the combustor is provided. The method includes: supplying the fuel to the combustor; obtaining a property value of at least one physical property (PTB, PT7, Tinlet, THBOV) of air used for burning the fuel in the combustor; estimating a heat input (HIengmodel) of the fuel supplied to the combustor based on the property value; measuring a Caloric Value (LCVmea) of the fuel upstream of the combustor; adjusting the estimated heat input (HIengmodel) based on the measured Caloric Value (LCVmea); and controlling a fuel valve regulating the supply of the fuel to the combustor based on the adjusted estimated heat input (HIexpected) and a demanded heat input (FFDEM).
    Type: Application
    Filed: November 5, 2013
    Publication date: November 5, 2015
    Applicant: Siemens Aktiengesellschaft
    Inventors: Gareth Huw Davies, Michael Smith
  • Publication number: 20150148321
    Abstract: The disclosure relates to novel C4 and C6 substituted androst-4-ene diones as well as andros-1,4-diene diones and derivatives thereof, their process of preparation, pharmaceutical compounds containing them, and the use of said compounds for the treatment of hormone-related disorders in mammals. This includes hormone-dependent cancers, particularly those caused by elevated levels of estrogen and its intermediates. These compounds can also be used in the treatment of other hormone-related disorders, including benign prostatic hyperplasia, cardiovascular disease, and neurodegenerative disorders.
    Type: Application
    Filed: January 27, 2015
    Publication date: May 28, 2015
    Inventors: Huw Davies, Debashis Ghosh, Daniel Morton
  • Patent number: 8969327
    Abstract: The disclosure relates to novel C4 and C6 substituted androst-4-ene diones as well as andros-1,4-diene diones and derivatives thereof, their process of preparation, pharmaceutical compounds containing them, and the use of said compounds for the treatment of hormone-related disorders in mammals. This includes hormone-dependent cancers, particularly those caused by elevated levels of estrogen and its intermediates. These compounds can also be used in the treatment of other hormone-related disorders, including benign prostatic hyperplasia, cardiovascular disease, and neurodegenerative disorders.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: March 3, 2015
    Assignees: Emory University, The Research Foundation of State of New York, Hauptman-Woodward Medical Research Institute
    Inventors: Huw Davies, Dabashis Ghosh, Daniel Morton
  • Publication number: 20150056241
    Abstract: Contemplated compositions, devices, and methods comprise immunodominant antigens from selected human pathogens (Burkholderia pseudomallei, Borrelia burgdorferi, Brucella melitensis, Chlamydia muridarum, Coxiella burnetii, Francisella tularensis, human Herpes virus 1 and 2, Mycobacterium tuberculosis, Plasmodium falciparum, and Vaccinia virus) can be used as a vaccine, as diagnostic markers, and as therapeutic agents. In particularly preferred aspects, the antigens have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and have a known association with a disease parameter.
    Type: Application
    Filed: October 20, 2014
    Publication date: February 26, 2015
    Inventors: Philip Felgner, David Huw Davies, Xiaowu Liang
  • Publication number: 20150037367
    Abstract: Contemplated compositions, devices, and methods are drawn to various antigens from Herpes Simplex Virus type 1 (HSV-1) and Herpes Simplex Virus type 2 (HSV-2) and their use in vaccines, therapeutic agents, and various diagnostic tests. In particularly preferred aspects, the antigens are immunodominant and have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and/or have a known association with a disease parameter.
    Type: Application
    Filed: June 29, 2012
    Publication date: February 5, 2015
    Inventors: David Huw Davies, Xiaowu Liang, Philip Felgner
  • Publication number: 20140117158
    Abstract: An aircraft wing assembly comprising a wing (2) having a wing box structure including an upper wing cover (7) and a lower wing cover (8), and a wing tip device (1) attached to the outboard end of the wing, the wing tip device including an upper cover (9) and a lower cover (10), wherein a gap (g) between opposing edges of the wing tip device lower cover (10) and the lower wing cover (8) is at least 5 mm, and further comprising a seal assembly (20) for aerodynamically sealing the gap (g), wherein the seal assembly (20) includes a bridging component (21) on an interior side of the gap (g), and a seal (22) which fills the gap (g) and is supported by the bridging component (21). Also, an aircraft having the wing assembly, and a method of attaching a wing tip device (1) to the outboard end of a wing (2).
    Type: Application
    Filed: April 23, 2012
    Publication date: May 1, 2014
    Applicant: AIRBUS OPERATIONS LIMITED
    Inventors: Huw Davies, Nigel McKenna
  • Publication number: 20140004141
    Abstract: Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen T. gondii and their use in various diagnostic tests, vaccines, and therapeutic agents. In particularly preferred aspects, the antigens are immunodominant and have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and/or have a known association with a disease parameter.
    Type: Application
    Filed: December 20, 2011
    Publication date: January 2, 2014
    Applicant: Immport Therapeutics, Inc.
    Inventors: David Huw Davies, Xiaowu Liang, Philip Felgner
  • Patent number: 8590317
    Abstract: A method of starting a gas turbine engine by use of a start sequence is provided. Turbine speed and fuel delivery are coordinated so as to provide a fuel/air mixture at an ignition device allowing a successful ignition. If a successful ignition has not occurred by end of the start sequence the gas turbine engine is purged and the start sequence is repeated after the purging of the gas turbine engine.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: November 26, 2013
    Assignee: Siemens Aktiengesellschaft
    Inventors: Gareth Huw Davies, Richard Woods, Stuart Wilkinson, Maria Helen Kathalin Wilkinson
  • Patent number: 8567174
    Abstract: A valve assembly is provided for a gas turbine engine with at least two drain valves connected to the gas turbine engine to drain oil and moisture from the engine, an actuator for opening and closing the at least two drain valves, a solenoid valve connected to the actuator and to a regulated air supply for driving the actuator and a safety valve connected to an exhaust of the solenoid valve and to a compressor air supply, the compressor air supply driving the safety valve to prevent the actuator from being vented during engine operation. A method of securely operating a plurality of drain valves is also provided.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: October 29, 2013
    Assignee: Siemens Aktiengesellschaft
    Inventors: Edward Burkitt, Gareth Huw Davies
  • Publication number: 20130157988
    Abstract: The disclosure relates to novel C4 and C6 substituted androst-4-ene diones as well as andros-1,4-diene diones and derivatives thereof, their process of preparation, pharmaceutical compounds containing them, and the use of said compounds for the treatment of hormone-related disorders in mammals. This includes hormone-dependent cancers, particularly those caused by elevated levels of estrogen and its intermediates. These compounds can also be used in the treatment of other hormone-related disorders, including benign prostatic hyperplasia, cardiovascular disease, and neurodegenerative disorders.
    Type: Application
    Filed: April 7, 2011
    Publication date: June 20, 2013
    Applicants: EMORY UNIVERSITY, HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, THE RESEARCH FOUNDATION OF STATE OF NEW YORK
    Inventors: Huw Davies, Debashis Ghosh, Daniel Morton
  • Publication number: 20100293960
    Abstract: A method of starting a gas turbine engine by use of a start sequence is provided. Turbine speed and fuel delivery are coordinated so as to provide a fuel/air mixture at an ignition device allowing a successful ignition. If a successful ignition has not occurred by end of the start sequence the gas turbine engine is purged and the start sequence is repeated after the purging of the gas turbine engine.
    Type: Application
    Filed: February 27, 2007
    Publication date: November 25, 2010
    Inventors: Gareth Huw Davies, John Wilkinson, Stuart Wilkinson, Maria Helen Kathakin Wilkinson, Richard Woods
  • Patent number: 7740162
    Abstract: Two aluminium alloy work-pieces are welded together. Firstly, a portion (2) of each work-piece (1) is prepared, the preparation including the performance of a surface treatment, such as friction stir welding, that results in a region (A) extending from the exterior surface into the work-piece having a grain structure that is finer than the grain structure of the work-piece outside (region C) that region. Then the work-pieces are welded together by means of a fusion welding process, such as electron beam welding, that joins the respective prepared portions (2) of the two work-pieces (1). The preparation of the work-pieces is so performed that said region (A) extends into the work-piece to a depth that exceeds the depth of material (region D) that is caused to melt during the fusion welding process.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: June 22, 2010
    Assignee: Airbus UK, Limited
    Inventors: Rostyslav Ilyushenko, Robert Jan Maziarz, Huw Davies
  • Publication number: 20100125962
    Abstract: Toothbrush having a head, a neck and a handle, the toothbrush comprising a plastic body and a metal skeleton, the plastic body being moulded around the metal skeleton, the metal skeleton extending from the handle through the neck and into the head of the toothbrush.
    Type: Application
    Filed: March 7, 2008
    Publication date: May 27, 2010
    Inventors: Richard Huw Davies, Giorgia Deplano, Derek Savill
  • Publication number: 20100119535
    Abstract: Contemplated compositions, devices, and methods comprise immunodominant antigens from selected human pathogens (Burkholderia pseudomallei, Borrelia burgdorferi, Brucella melitensis, Chlamydia muridarum, Coxiella burnetii, Francisella tularensis, human Herpes virus 1 and 2, Mycobacterium tuberculosis, Plasmodium falciparum, and Vaccinia virus) can be used as a vaccine, as diagnostic markers, and as therapeutic agents. In particularly preferred aspects, the antigens have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and have a known association with a disease parameter.
    Type: Application
    Filed: November 1, 2007
    Publication date: May 13, 2010
    Applicant: IMMPORT THERAPEUTICS, INC.
    Inventors: Philip Felgner, David Huw Davies, Xiaowu Liang
  • Publication number: 20080260763
    Abstract: Methods to obtain expression systems and proteins in a high-throughput protocol by utilizing mixtures of cells cultured from those transformed with a desired nucleotide sequence permit rapid production of protein for use in arrays to assess activity. In one embodiment, the proteins (or peptides) in the array are assessed for their immunological activity with regard to an infectious agent.
    Type: Application
    Filed: July 1, 2005
    Publication date: October 23, 2008
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Philip Felgner, Huw Davies, Xiaowu Liang
  • Patent number: 7393533
    Abstract: The invention relates to, among other things, methods of protecting against poxvirus infection or pathogenesis and including pox viruses such as small pox (variola major and variola minor), cowpox, monkey pox vaccinia virus, and Molluscum Contagiosum using compositions such as human, humanized and chimeric antibodies that specifically bind to H3L protein.
    Type: Grant
    Filed: November 8, 2005
    Date of Patent: July 1, 2008
    Assignee: La Jolla Institute for Allergy and Immunology
    Inventors: Shane Crotty, Philip L Felgner, David Huw Davies
  • Publication number: 20070249646
    Abstract: Disclosed are methods for alleviating symptoms of neuropsychiatric disorders using tetrahydropyridine derivatives bearing aromatic substituents. The method comprises administering to an individual a tetrahydropyridine derivative bearing aromatic substituents in an amount effective to alleviate symptoms of the neuropsychiatric disorder.
    Type: Application
    Filed: March 12, 2007
    Publication date: October 25, 2007
    Inventors: Huw Davies, Anil Ratty
  • Publication number: 20070244201
    Abstract: Disclosed are aromatic cyclopropane compounds with CNS activity. These compounds can be used for alleviating symptoms of CNS disorders.
    Type: Application
    Filed: March 12, 2007
    Publication date: October 18, 2007
    Inventors: Huw Davies, Timothy Gregg
  • Publication number: 20070232646
    Abstract: Disclosed are tropane-based prodrug compounds bearing fatty ester and aromatic substituents. The compounds can be used for alleviating symptoms of CNS disorders.
    Type: Application
    Filed: March 12, 2007
    Publication date: October 4, 2007
    Inventor: Huw Davies
  • Publication number: 20070232587
    Abstract: Disclosed are novel homotropane compounds with CNS activity. These compounds can be used for alleviating symptoms of CNS disorders.
    Type: Application
    Filed: March 12, 2007
    Publication date: October 4, 2007
    Inventor: Huw Davies